DeepMed IO is a MedTech company based in the UK. Our mission is to use AI to increase the accuracy and speed of diagnostic processes and deliver personalized care solutions for patients, thus prolonging their survival and improving their quality of life. Our exceptional team of experienced bioinformaticians and machine learning experts work hard around the clock to deliver AI tools with practical use in the clinic.
DeepMed I/O: Detection Of Metastasis On LYMPH NODES
Detection of metastases in hematoxylin and eosin stained slides of lymph node sections is of high clinical relevance but requires large amounts of reading time from histopathologists, whose numbers are inadequate to meet the demand at a global scale and has a major contribution to diagnostic bottlenecks all over the world. In the UK this translates to more than 13,000 people waiting for more than 2 months to start treatment at any given time. We are currently developing a deep learning powered system for automatic detection of metastatic regions on lymph-node sections. This system will serve as an augmentation tool for pathologists increasing diagnostic speed and accuracy.